What is NDC 0093-7536?

0093-7536 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, film coated, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anastrozole?

38 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anastrozole NDC 0093-7536 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-7536Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-7536Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-7536-56	0009375365600093753656	30 TABLET, FILM COATED in 1 BOTTLE (0093-7536-56)Marketed from Jun 28, 2010

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anastrozole
Generic name (nonproprietary): anastrozole
Active ingredients: Anastrozole — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078058
Marketing start: Jun 28, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Aromatase Inhibitors (Mechanism)
Identifiers: Product ID 0093-7536_a02eea00-78b1-4cf8-93f7-5d43f59722f0SPL ID a02eea00-78b1-4cf8-93f7-5d43f59722f0SPL set ID c58c7013-50a0-4734-8a78-38ff20a3e7ebRxCUI 199224UNII 2Z07MYW1AZUPC 0300937536567
Pharmacologic class: Aromatase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093753656 followed by a unit qualifier and the quantity

Package 00093-7536-56. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 14, 2025.

Indications (excerpt from the label)

Anastrozole tablets are an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer ( 1.1 ) First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1.2 ) Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets. ( 1.3 ) 1.1 Adjuvant Treatment Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone re…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-7536

What is NDC 0093-7536?: 0093-7536 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, film coated, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anastrozole.
What is the active ingredient?: Anastrozole.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anastrozole?: 38 other product NDCs are listed under this name. See all Anastrozole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Anastrozole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-682	72189-0682-30
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-575	72789-0575-1572789-0575-30
Anastrozoleanastrozole tablets	Anastrozole 1 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	24979-725	24979-0725-0624979-0725-07
Anastrozole	Anastrozole 1 mg/1	TabletOral	AvKARE	42291-016	42291-0016-3042291-0016-90
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-415	72189-0415-30
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-236	59651-0236-3059651-0236-90
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	AvKARE	42291-085	42291-0085-3042291-0085-90
Anastrozole	Anastrozole 1 mg/1	TabletOral	AvPAK	50268-075	50268-0075-15
Anastrozoleanastrozole tablets	Anastrozole 1 mg/1	TabletOral	Avet Pharmaceuticals Inc	23155-857	23155-0857-0323155-0857-0523155-0857-09
Anastrozole	Anastrozole 1 mg/1	TabletOral	Chartwell RX, LLC	62135-490	62135-0490-3062135-0490-90

All 39 Anastrozole NDCs

Other NDCs under ANDA 078058

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078058
Product	Strength	Form · route	Labeler	Product NDC
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	AvKARE	42291-085